-
Signature
-
/s/ Brian E. Anderson, attorney-in-fact for Brian Lieser
-
Issuer symbol
-
BDC
-
Transactions as of
-
13 May 2025
-
Net transactions value
-
-$62,410
-
Form type
-
4
-
Filing time
-
14 May 2025, 17:56:11 UTC
Reporting Owners (1)
| Name |
Relationship |
Address |
Signature |
Signature date |
CIK |
| Lieser Brian |
EVP, Automation Solutions |
C/O BELDEN INC., 1 N. BRENTWOOD BLVD., 15TH FLOOR, ST. LOUIS |
/s/ Brian E. Anderson, attorney-in-fact for Brian Lieser |
14 May 2025 |
0001967061 |
Transactions Table
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Ownership |
Footnotes |
| transaction |
BDC |
Common Stock |
Options Exercise |
$74,148 |
+1,200 |
+3.2% |
$61.79 |
38,605 |
13 May 2025 |
Direct |
F1 |
| transaction |
BDC |
Common Stock |
Disposed to Issuer |
$102,807 |
-903 |
-2.3% |
$113.85 |
37,702 |
13 May 2025 |
Direct |
F3 |
| transaction |
BDC |
Common Stock |
Sale |
$33,751 |
-297 |
-0.79% |
$113.64 |
37,405 |
14 May 2025 |
Direct |
F4 |
| holding |
BDC |
Common Stock |
|
|
|
|
|
505 |
13 May 2025 |
By 401(k) Plan |
F2 |
Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)
| Type |
Sym |
Class |
Transaction |
Value $ |
Shares |
Change % |
* Price $ |
Shares After |
Date |
Underlying Class |
Amount |
Exercise Price |
Ownership |
Footnotes |
| transaction |
BDC |
Stock Appreciation Rights |
Options Exercise |
$0 |
-1,200 |
-35% |
$0.000000 |
2,266 |
13 May 2025 |
Common Stock |
1,200 |
$61.79 |
Direct |
F1, F5 |
* An asterisk sign (*) next to the price indicates that the price is likely invalid.
Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.
Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).
Explanation of Responses: